{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T10:26:29Z","timestamp":1791109589724,"version":"4.1.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"vor","delay-in-days":5825,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1016\/j.jpainsymman.2003.06.010","type":"journal-article","created":{"date-parts":[[2004,2,10]],"date-time":"2004-02-10T05:17:53Z","timestamp":1076390273000},"page":"185-190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"title":["The decision to prematurely terminate a trial of R-HuEPO due to thrombotic events"],"prefix":"10.1016","volume":"27","author":[{"given":"Margaret Q.","family":"Rosenzweig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Bender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph P.","family":"Lucke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce M.","family":"Yasko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam M.","family":"Brufsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpainsymman.2003.06.010_BIB1","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1056\/NEJM199006143222402","article-title":"Erythropoietin treatment of anemia associated with multiple myeloma","volume":"322","author":"Ludwig","year":"1990","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.jpainsymman.2003.06.010_BIB2","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1200\/JCO.1991.9.11.2021","article-title":"Treatment of chemotherapy-induced anemia with recombinant human erythropoietin in cancer patients","volume":"9","author":"Platanias","year":"1991","journal-title":"J Clin Oncol"},{"issue":"Supp 2","key":"10.1016\/j.jpainsymman.2003.06.010_BIB3","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S0959-8049(05)80281-3","article-title":"Erythropoietin for anemia in cancer patients","volume":"29A","author":"Abels","year":"1993","journal-title":"Eur J Cancer"},{"issue":"2; Supp 3","key":"10.1016\/j.jpainsymman.2003.06.010_BIB4","first-page":"21","article-title":"Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: results of double blind\/open label follow up studies","volume":"21","author":"Henry","year":"1994","journal-title":"Semin Oncol"},{"issue":"10","key":"10.1016\/j.jpainsymman.2003.06.010_BIB5","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/00001813-199711000-00006","article-title":"A multicenter study of recombinant human erythropoietin (epoetin alpha) in the management of anemia in cancer patients receiving chemotherapy","volume":"8","author":"Pawlicki","year":"1997","journal-title":"Anticancer Drugs"},{"issue":"3","key":"10.1016\/j.jpainsymman.2003.06.010_BIB6","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1200\/JCO.1997.15.3.1218","article-title":"Impact of therapy with epoetin alpha on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice","volume":"15","author":"Glaspy","year":"1997","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.jpainsymman.2003.06.010_BIB7","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1200\/JCO.1998.16.10.3412","article-title":"Quality of life benefit in chemotherapy patients treated with epoetin alpha is independent of disease response or tumor type: results from a prospective community oncology study","volume":"16","author":"Demetri","year":"1998","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.jpainsymman.2003.06.010_BIB8","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1200\/JCO.2001.19.11.2875","article-title":"Clinical evaluation of once weekly dosing of epoetin-alpha in chemotherapy: improvements in hemoglobin and quality of life are similar in three times weekly dosing","volume":"19","author":"Gabrilove","year":"2001","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.jpainsymman.2003.06.010_BIB9","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1200\/JCO.2001.19.11.2865","article-title":"Effects of epoetin alpha on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind placebo controlled trial","volume":"19","author":"Littlewood","year":"2001","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.jpainsymman.2003.06.010_BIB10","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/0360-3016(94)90403-0","article-title":"Erythropoietin increases hemoglobin during radiation therapy for cervical cancer","volume":"29","author":"Dusenberry","year":"1994","journal-title":"Int J Radiat Oncol Bio-Physics"},{"key":"10.1016\/j.jpainsymman.2003.06.010_BIB11","series-title":"Blood cell growth factors: their present and future use in hematology and oncology","article-title":"Recombinant human erythropoietin (r-HuEPO) for the treatment of the anemia of cancer","author":"Abels","year":"1991"},{"key":"10.1016\/j.jpainsymman.2003.06.010_BIB12","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S0140-6736(94)90008-6","article-title":"Double-blind randomized trial of very low dose warfarin for prevention of thromboembolism in stage IV breast cancer","volume":"343","author":"Levine","year":"1994","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jpainsymman.2003.06.010_BIB13","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1200\/JCO.1991.9.2.286","article-title":"Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer","volume":"9","author":"Saphner","year":"1991","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.jpainsymman.2003.06.010_BIB14","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1200\/JCO.1994.12.6.1266","article-title":"Thromboembolic complications after perioperative chemotherapy in women with early breast cancer: a European organization for research and treatment of cancer breast cancer cooperative group study","volume":"12","author":"Clahsen","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jpainsymman.2003.06.010_BIB15","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/1097-0142(19841001)54:7<1264::AID-CNCR2820540706>3.0.CO;2-R","article-title":"Increased incidence of thromboembolism is Stage IV breast cancer patients treated with a 5 drug chemotherapy regimen","volume":"54","author":"Goodnough","year":"1984","journal-title":"Cancer"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392403005128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392403005128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:54:26Z","timestamp":1760129666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0885392403005128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["S0885392403005128"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2003.06.010","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2004,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The decision to prematurely terminate a trial of R-HuEPO due to thrombotic events","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2003.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}